We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.9B
1-Year Est. Return
42.31%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$4.85B
AUM Growth
+$1.14B
(+31%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
22.01%
Top 10 Holdings %
Top 10 Hldgs %
53.88%
Holding
153
New
63
Increased
23
Reduced
14
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$356M |
| 2 |
Amazon
AMZN
|
+$325M |
| 3 |
Broadcom
AVGO
|
+$218M |
| 4 |
MON
Monsanto Co
MON
|
+$163M |
| 5 |
Constellation Brands
STZ
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$371M |
| 2 |
AGN
Allergan plc
AGN
|
+$207M |
| 3 |
Cheniere Energy
LNG
|
+$195M |
| 4 |
Charter Communications
CHTR
|
+$153M |
| 5 |
McDonald's
MCD
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.94% |
| 2 | Energy | 13.27% |
| 3 | Communication Services | 10.39% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAP
76
The Gap Inc
GAP
$7.3B
| $3.1M | 0.06% |
+145,900
| New | +$3.11M |
|
77
Eaton
ETN
$141B
| $3.01M | 0.06% |
+50,400
| New | +$3.1M |
|
78
Boyd Gaming
BYD
$6.75B
| $2.95M | 0.06% |
+160,400
| New | +$3.11M |
|
79
Sarepta Therapeutics
SRPT
$1.64B
| $2.86M | 0.06% |
150,000
-750,000
| -83% | -$13.9M |
|
80
Nektar Therapeutics
NKTR
$2.39B
| $2.85M | 0.06% |
+13,333
| New | +$2.98M |
|
|
GNC
81
DELISTED
GNC Holdings, Inc.
GNC
| $2.79M | 0.06% |
+114,700
| New | +$3.17M |
|
82
Under Armour
UAA
$3.01B
| $2.7M | 0.06% |
+67,300
| New | +$2.67M |
|
|
MGP
83
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $2.3M | 0.05% |
+86,120
| New | +$2.05M |
|
84
Dillards
DDS
$9.2B
| $2.17M | 0.04% |
+35,800
| New | +$2.34M |
|
85
Starbucks
SBUX
$119B
| $2.14M | 0.04% |
+37,500
| New | +$2.13M |
|
86
Designer Brands
DBI
$315M
| $2.09M | 0.04% |
+98,800
| New | +$2.27M |
|
87
AutoZone
AZO
$51.3B
| $1.99M | 0.04% |
+2,500
| New | +$1.93M |
|
|
ODP
88
DELISTED
ODP
ODP
| $1.81M | 0.04% |
+54,680
| New | +$2.67M |
|
89
PUT
iShares S&P 100 ETF
OEF
$19.5B
| $1.73M | 0.04% |
+15,000
| New | +$1.38M |
|
90
Adobe
ADBE
$105B
| $1.49M | 0.03% |
+15,500
| New | +$1.49M |
|
|
AMJ
91
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.47M | 0.03% |
+46,100
| New | +$1.37M |
|
|
GNC
92
CALL
DELISTED
GNC Holdings, Inc.
GNC
| $1.22M | 0.03% |
+50,000
| New | +$1.38M |
|
93
Molson Coors Class B
TAP
$8.02B
| $1.08M | 0.02% |
10,658
-20,842
| -66% | -$2.05M |
|
|
94
CALL
Constellation Brands
STZ
$22.5B
| $1.07M | 0.02% |
+6,500
| New | +$1.02M |
|
|
GAP
95
CALL
The Gap Inc
GAP
$7.3B
| $1.06M | 0.02% |
+50,000
| New | +$1.06M |
|
96
Dover
DOV
$26.7B
| $915K | 0.02% |
+16,342
| New | +$881K |
|
97
Outlook Therapeutics
OTLK
$187M
| $680K | 0.01% |
+1,250
| New | +$746K |
|
98
FMC
FMC
$1.25B
| $667K | 0.01% |
+16,603
| New | +$651K |
|
|
BERY
99
DELISTED
Berry Global Group, Inc.
BERY
| $660K | 0.01% |
+18,513
| New | +$633K |
|
100
Telecom Argentina
TEO
$5.84B
| $495K | 0.01% |
27,000
| – | – |
|
Similar funds
CIP
IMRF
SF
CMTU
PGFC
EGM
PA
MT
PointState Capital's Q2 2016 Portfolio in Review
As of Q2 2016, PointState Capital held 153 positions worth $4.85B, up 31% from $3.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
PointState Capital deployed $1.07B of net new capital in Q2 2016, opening 63 new positions and adding to 23 existing holdings. Its largest new stake was Broadcom: 14,318,500 shares worth $223M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 38% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was Allergan plc, an estimated $207M trimmed.
- PointState Capital's largest Q2 2016 buy was Broadcom: 14,318,500 shares worth $223M.
- PointState Capital added most to Teva Pharmaceuticals in Q2 2016, an estimated $356M increase.
- PointState Capital's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $207M.
- PointState Capital fully exited LyondellBasell Industries in Q2 2016, selling an estimated $371M.
- PointState Capital's ten largest holdings make up 54% of its $4.85B portfolio in Q2 2016.
- PointState Capital opened 63 new positions and closed 45 in Q2 2016.
- PointState Capital's portfolio value rose 31% quarter-over-quarter to $4.85B.
Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.